AIDS. Promote HIV chemoprophylaxis research, don't prevent it.
about
Antiretroviral pre-exposure prophylaxis prevents vaginal transmission of HIV-1 in humanized BLT miceThe spread, treatment, and prevention of HIV-1: evolution of a global pandemicAntiretroviral pre-exposure prophylaxis (PrEP) for preventing HIV in high-risk individualsPreexposure chemoprophylaxis for HIV prevention in men who have sex with menEnrolling women into HIV preventive vaccine trials: an ethical imperative but a logistical challenge.Prevention of rectal SHIV transmission in macaques by daily or intermittent prophylaxis with emtricitabine and tenofovirSystemic administration of antiretrovirals prior to exposure prevents rectal and intravenous HIV-1 transmission in humanized BLT miceHIV preexposure prophylaxis in the United States: impact on lifetime infection risk, clinical outcomes, and cost-effectivenessPre-exposure prophylaxis for the prevention of HIV infection in high risk populations: a meta-analysis of randomized controlled trialsPotential impact of antiretroviral chemoprophylaxis on HIV-1 transmission in resource-limited settingsCan the new humanized mouse model give HIV research a boostAntiretroviral therapy for prevention of HIV infection: new clues from an animal model.The impact of pre-exposure prophylaxis (PrEP) on HIV epidemics in Africa and India: a simulation study.Legal and ethical values in the resolution of research-related disputes: how can IRBS respond to participant complaints?Cultural conundrums: the ethics of epidemiology and the problems of population in implementing pre-exposure prophylaxis.Preexposure prophylaxis and predicted condom use among high-risk men who have sex with menSetting the bar high or setting up to fail? Interpretations and implications of the EXPLORE Study (HPTN 015).Pre-exposure prophylaxis of HIV: A right way to go or a long way to go?Protection against rectal transmission of an emtricitabine-resistant simian/human immunodeficiency virus SHIV162p3M184V mutant by intermittent prophylaxis with Truvada.Partnering for Care in HIV Prevention TrialsPractice brief: adolescents and HIV clinical trials: ethics, culture, and context.Antiretroviral agents used by HIV-uninfected persons for prevention: pre- and postexposure prophylaxis.Mucosal HIV-1 transmission and prevention strategies in BLT humanized miceA macaque model of HIV-1 infectionPrevention of vaginal and rectal HIV transmission by antiretroviral combinations in humanized mice.From subjects to relations: Bioethics and the articulation of postcolonial politics in the Cambodia Pre-Exposure Prophylaxis trial.Saying 'No' to PrEP research in Malawi: what constitutes 'failure' in offshored HIV prevention research?Challenges in microbicide trial design and implementation.Southern African guidelines on the safe use of pre-exposure prophylaxis in persons at risk of acquiring HIV-1 infection.Protection Efficacy of C5A Against Vaginal and Rectal HIV Challenges in Humanized Mice.
P2860
Q21144657-03FCF916-0B7C-44D1-8AA9-E007EC2A292FQ22241890-CD6D851A-D2B2-40E7-A820-6458FAF2EB9DQ24241184-86FB746D-F5F6-44FC-B98D-52F1D426E973Q24612082-0B2A6C68-3BE3-4ABD-B133-C19A45FC2A2DQ25255907-F081F05B-0C77-4349-8877-3FDD77742090Q28472146-C2B2551B-1AFB-42A8-A46D-9D454C12FFE6Q28472590-5739AA25-17DB-4EF1-80A6-BFA3883FFCB7Q28474086-1A7F9099-28F9-4563-9C31-7CA5B3F4D448Q28539443-DC7ED8F2-CD34-4118-B1D0-792E0167165CQ33299456-A6BD6721-A120-4B1F-B8EA-29B840D53064Q33315029-EE64BB47-EBE4-4911-AC9B-324C195C2D9AQ33318541-F08D79D5-98D8-488F-BA8A-2428F29C0273Q33332191-127EA5DC-9BCF-40BC-A671-819F689A70E8Q33696526-2090FAD9-882B-444B-BCE5-7234AD809A80Q33794164-D20FF751-B528-495E-8322-AB645D3269B1Q34012348-979D75AE-AAD9-499E-8E1B-90D0F594441DQ34986930-5344B88F-C420-402A-A0D0-3AAD41B1296CQ35033732-2E049737-81E2-4CF6-A396-A9673C82AAEBQ35140323-4B06D383-EB07-47EB-A4EC-A273B4A17CF9Q35629374-622D25D3-371C-4104-AC92-8AD046BBBFF6Q36113915-4E16AFB0-902C-4212-A96A-94CF164CA1A3Q36873010-60D45DD4-B6A8-40C4-9D09-CDF2351E0A97Q36923075-6A59C7BE-0AD7-4A69-BB56-B8D68C79CC12Q37132808-E96DA402-6344-45BB-A9A3-B9ACF1366308Q40062702-0EB3F429-9EB3-4A24-80C0-0390067FD351Q40645050-DA76B4B4-77CF-4EFB-A3D7-0DE3BE55CA33Q40973780-8F5D9E5C-2432-4999-A80C-E878A9FCCCAAQ46219584-183DF684-0C04-443D-9256-D82E11822C93Q53769213-F139789C-1F69-4F77-A5C0-89A7D1E72F02Q53837345-6334A571-D03E-4113-85B6-661610F776CE
P2860
AIDS. Promote HIV chemoprophylaxis research, don't prevent it.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
AIDS. Promote HIV chemoprophylaxis research, don't prevent it.
@en
AIDS. Promote HIV chemoprophylaxis research, don't prevent it.
@nl
type
label
AIDS. Promote HIV chemoprophylaxis research, don't prevent it.
@en
AIDS. Promote HIV chemoprophylaxis research, don't prevent it.
@nl
prefLabel
AIDS. Promote HIV chemoprophylaxis research, don't prevent it.
@en
AIDS. Promote HIV chemoprophylaxis research, don't prevent it.
@nl
P2093
P50
P356
P1433
P1476
AIDS. Promote HIV chemoprophylaxis research, don't prevent it.
@en
P2093
Edith Clarke
Guiselly Flores
Javier R Lama
John P Moore
Jorge Sanchez
Kathleen M MacQueen
Leigh Peterson
Mark A Wainberg
Mark Harrington
Martin Delaney
P304
P356
10.1126/SCIENCE.1116204
P407
P577
2005-09-01T00:00:00Z